Ivabradine Shows Promise as Tx for Hyperadrenergic POTS

Further study needed in other POTS subtypes In patients with hyperadrenergic postural orthostatic tachycardia syndrome (POTS), one month of treatment with ivabradine brought about significant improvements in several parameters, including heart rate, quality of life (QOL), and plasma norepinephrine (NE) levels, according to results from a recent study published in the Journal of the American

Ivabradine effects on COVID-19-associated postural orthostatic

POTS Treatment: Scientifically & Medically Proven • MyHeart

PDF) Age-dependent modulation of xenobiotic metabolism in primary

Potential role of Ivabradine in children with Long Covid and a

Karsten HEUSSER, Senior Physician Scientist

Postural orthostatic tachycardia syndrome (POTS): a common but

Ivabradine Knocks Down Heart Rate, Symptoms in POTS

Physiological effects of ivabradine in heart failure and beyond

I know this subreddit is likely skewed to those of us who are